BCSF · Bain Capital Specialty Finance, Inc.
Market Cap
$728.47M
Shares
64.87M
Volume · Oct 5
623.64K
Avg daily vol (3M)
420.65K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.05
Open$11.20
Day$10.98–11.21
52W close$11.04–14.60
Avg vol 30d515K
Short int1.7M · 2.5% float · 3.1d
Short vol45%
Last earningsAug 11, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 10
Up next
filed Aug 10, 2026
call held May 12, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$263.96M
Trailing 12 months
Net income (TTM)
$63.93M
Trailing 12 months
Revenue growth YoY
-12.1%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
11.2
Trailing earnings · reciprocal yield 9.0%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$1.40B
Latest balance sheet
Dividend yield
16.8%
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-22.1%
Trailing year
Short interest
2.5%
Latest settlement · 3.1 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Low
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−14%
below
Price vs 50-day avg
−7%
below
RSI (14)
36
neutral
MACD trend
Positive
52-week position
0%
near low
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−13%
trailing
YTD return
−21%
this year
Relative strength
−25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $12 › 200d $13 — 200d above 50d
Institutional flow
Accumulating
1 of 130 funds reported for Sep 30 · net +2.5K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.54% of float · ▲ +10.1% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
130 holders — mid 3-yr range
Squeeze score
55
elevated · 0–100
Fundamentals
EPS growth
−17%
Y/Y
Valuation
P/E 11.3
below peers
Buyback
$50.0M
authorized
Balance sheet
$1.4B
net debt
Quant / Vol
risk profile
Volatility
24%
annualized · 1-yr
Max drawdown
−24%
past year
ATR
2.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−14%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
36
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $12 › 200d $13 — 200d above 50d
Institutional flow
Accumulating
1 of 130 funds reported for Sep 30 · net +2.5K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.54% of float · ▲ +10.1% MoM · 3.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
130 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $11
Now $11 · 0%
Range high $15
vs 200-day avg -14%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Annualized NII yield on book value non-GAAP | 10.5% | Q2 2026 | — |
| Annualized return on book value non-GAAP | 5.2% | Q2 2026 | — |
| Capacity under Sumitomo Credit Facility | $606M | Q2 2026 | — |
| Floating rate debt investments (% of debt investments at fair value) | 94.5% | Q2 2026 | — |
| Fundings in existing companies | $108.6M | Q2 2026 | — |
| Fundings in new companies | $73.4M | Q2 2026 | — |
| Gross investment fundings | $182M | Q2 2026 | — |
| Investments on non-accrual (% of total investment portfolio at amortized cost) | 3.2% | Q2 2026 | — |
| Investments on non-accrual (% of total investment portfolio at fair value) | 2.2% | Q2 2026 | — |
| Net asset value per share | $16.65 | Q2 2026 | — |
| Net investment fundings | -$95.2M | Q2 2026 | — |
| New portfolio companies invested in (count) | 8 | Q2 2026 | — |
| Per share net increase in net assets resulting from operations | $0.22 | the three months ended June 30, 2026 filing | — |
| Portfolio companies invested in (count) | 99 | Q2 2026 | — |
| Undrawn investment commitments | $438M | Q2 2026 | — |
| Weighted average yield on investment portfolio at amortized cost | 10.8% | Q2 2026 | — |
| Weighted average yield on investment portfolio at fair value | 10.4% | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BCSF
this stock
Bain Capital Specialty Finance, Inc.
|
$728.47M | -20.6% | — | 11.3 | 2.5% |
|
BLK
BlackRock, Inc.
|
$347.03B | -1.0% | +16.2% | 25.6 | 0.6% |
|
KKR
KKR & Co. Inc.
|
$86.77B | -29.2% | -11.0% | — | 1.5% |
|
BX
Blackstone Inc.
|
$85.57B | -27.5% | +9.2% | 25.6 | 2.6% |
|
BN
BROOKFIELD Corp /ON/
|
$81.46B | -19.5% | — | — | 0.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BCSF | -0.3% | -6.9% | -13.0% | +0.1% | -20.6% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -0.1% | -6.5% | -25.2% | -0.8% | -33.4% |
Capital returns
Latest dividend
$0.42
/ share · ex Sep 15, 2026
Paid (TTM)
$1.86
/ share · 5 payouts
Dividend yield (TTM, derived)
16.83%
Buyback program
· as of May 7, 2019
Authorized
$50.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.